Delivery Order SPE2DR25D1052-SPE2DR26F6CE2
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,143.87 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (semaglutide), a GLP-1 receptor agonist medication commonly used for weight management and diabetes treatment. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.56 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen (semaglutide injection), a pharmaceutical product used in diabetes and weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award carries...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,205.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen (semaglutide injection), a GLP-1 receptor agonist commonly prescribed for weight management. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,607.35 to AmerisourceBergen Drug Corp for ZEPBOUND 5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This firm fixed-price, competitively awarded delivery order was issued on June 10, 2025, with an ultimate completion date of June 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen (semaglutide injection), a diabetes and weight management medication. The contract, valued at $29,770.98, is a firm fixed-price delivery order with a completion date of October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.61 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist medication used for weight management. The contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a firm fixed price, non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens on September 27, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order represents a direct purchase of the FDA-approved diabetes and weight management medication through a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to the place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,928.19 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen (semaglutide injection), a diabetes and weight management medication. This firm fixed price, non-set-aside contract was executed on November 25, 2025, with an ultimate completion date of November 26, 2025, and performance to be delivered in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under...
- The Defense Logistics Agency awarded a delivery order valued at $1,897.68 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (semaglutide injection), a medication used for weight management and diabetes treatment. The award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....